Complementary medicine: Equity issues in evaluationand policy-making

Forschende Komplementarmedizin

Volumn 14, Issue SUPPL. 2, 2007, Pages 2-9

  Marian, Florica ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Complementary medicine; Equity; Fairness; Traditional medicine

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; DECISION MAKING; ECONOMICS; ETHICS; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; INSURANCE; MANAGEMENT; SWITZERLAND;

COMPLEMENTARY THERAPIES; DECISION MAKING; EVIDENCE-BASED MEDICINE; HEALTH POLICY; HUMANS; INSURANCE COVERAGE; POLICY MAKING; SWITZERLAND;

EID: 46649095282     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000112202     Document Type: Article

References (43)

1. Ernst E, Cohen MH, Stone J: Ethical problems arising in evidence based complementary and alternative medicine. J Med Ethics 2004;30:156-159.
2. Miller FG, Emanuel EJ, Rosenstein DL, Straus SE: Ethical issues concerning research in complementary and alternative medicine. Jama 2004;291: 599-604.
3. Sugarman J, Burk L: Physicians' ethical obligations regarding alternative medicine. Jama 1998;280: 1623-1625.
4. Adams KE, Cohen MH, Eisenberg D, Jonsen AR: Ethical considerations of complementary and alternative medical therapies in conventional medical settings. Ann Intern Med 2002;137:660-664.
5. Kerridge IH, McPhee JR: Ethical and legal issues at the interface of complementary and conventional medicine. Med J Aust 2004;181:164-166.
6. Daniels N, Sabin J: The ethics of accountability in managed care reform. Health Aff (Millwood) 1998; 17:50-64.
7. Slowther A, Ford S, Schofield T: Ethics of evidence based medicine in the primary care setting. J Med Ethics 2004;30:151-155.
8. Crivelli L: Slimming diet for the FHIA benefit basket; in: Health Policy Monitor. Lugano, Universita della Svizzera Italiana, 2005.
9. Walach H: The Swiss program for the evaluation of complementary medicine (PEK). J Altern Complement Med 2006;12:231-232.
10. Walach H, Linde K, Eichenberger R, Stalder H, Borlum Kristensen F, Kleijnen J: Summary consensus statement of the Review Board of the Swiss Complementary Medicine Evaluation Programme, (Programm Evaluation Komplementärmedizin, PEK) regarding the PEK process and products. Homeopathy 2006;95:28-30.
11. Heusser P: Medizin und Macht am Beispiel des Programms Evaluation Komplementärmedizin PEK; in Ausfeld-Hafter B (ed): Medizin und Macht. Die Arzt-Patienten-Beziehung im Wandel: Mehr Entscheidungsfreiheit? Bern, Peter Lang, 2007.
12. Heusser P: PEK und BAG: Probleme beim Programm Evaluation Komplementärmedizin. Schweiz Ärzteztg 2006;87:899-903.
13. Melchart D: Das Programm zur Evaluation der Komplementärmedizin (PEK) - ein fairer Versuch eines organisierten Dialogs zwischen Schulmedizin und Komplementärmedizin. Schweiz Ärzteztg 2005;86:934-937.
14. Melchart D, Mitscherlich F, Amiet M, Eichenberger R, Koch P: Programm Evaluation Komplementärmedizin (PEK) Schlussbericht. Bern, Bundesamt für Gesundheit, 2005.
15. Busato A, Donges A, Herren S, Widmer M, Marian F: Health status and health care utilisation of patients in complementary and conventional primary care in Switzerland - An observational study. Fam Pract 2006;23:116-124.
16. Widmer M, Herren S, Donges A, Marian F, Busato A: Complementary and conventional medicine in Switzerland: Comparing characteristics of general practitioners. Forsch Komplementärmed 2006;13: 234-240.
17. Marian F, Widmer M, Herren S, Donges A, Busato A: Physicians' philosophy of care: A comparison of complementary and conventional medicine. Forsch Komplementärmed 2006;13:70-77.
18. Walach H, Heusser P: [Effective or not? The decision is yours! - The PEK HTA reports]. Forsch Komplementärmed 2006;13(suppl 2):2-3.
19. Nartey L, Huwiler-Muntener K, Shang A, Liewald K, Juni P, Egger M: Matched-pair study showed higher quality of placebo-controlled trials in Western phytotherapy than conventional medicine. J Clin Epidemiol 2007;60:787-794.
20. Shang A, Huwiler K, Nartey L, Juni P, Egger M: Placebo-controlled trials of Chinese herbal medicine and conventional medicine - comparative study. Int J Epidemiol 2007;36:1086-1092.
21. Shang A, Huwiler-Muntener K, Nartey L, Juni P, Dorig S, Sterne JA, Pewsner D, Egger M: Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005;366: 726-732.
22. Fisher P, van Haselen R, Hardy K, Berkovitz S, Mc- Carney R: Effectiveness gaps: A new concept for evaluating health service and research needs applied to complementary and alternative medicine. J Altern Complement Med 2004;10:627-632.
23. Wynia MK, VanGeest JB, Cummins DS, Wilson IB: Do physicians not offer useful services because of coverage restrictions? Health Aff (Millwood) 2003; 22:190-197.
24. Lemann D: Komplementärmedizin und Krankenkassen. Wie rechnen komplementärmedizinisch tätige Ärzte zukünftig mit den Krankenkassen ab? Schweiz Z Ganzheitsmed 2005:266-268.
25. Brophy E: Does a doctor have a duty to provide information and advice about complementary and alternative medicine? J Law Med 2003;10:271-284.
26. Sugarman J: Informed consent, shared decisionmaking, and complementary and alternative medicine. J Law Med Ethics 2003;31:247-250.
27. Gotzsche PC: Research integrity and pharmaceutical industry sponsorship. Trial registration, transparency and less reliance on industry trials are essential. Med J Aust 2005;182:549-550.
28. Abraham J: The pharmaceutical industry as a political player. Lancet 2002;360:1498-1502.
29. Abraham J: Transnational industrial power, the medical profession and the regulatory state: Adverse drug reactions and the crisis over the safety of Halcion in the Netherlands and the UK. Soc Sci Med 2002;55:1671-1690.
30. Horn C, Scarano N (eds): Philosophie der Gerechtigkeit. Texte der Antike bis zur Gegenwart. Frankfurt/M., Suhrkamp, 2002.
31. Laupies F: La justice. Premières leçons. Paris, Presses Universitaires de France, 2005.
32. Culyer AJ: Equity - some theory and its policy implications. J Med Ethics 2001;27:275-283.
33. Braveman P, Gruskin S: Defining equity in health. J Epidemiol Community Health 2003;57:254-258.
34. Schweppenhäuser G: Grundbegriffe der Ethik. Hamburg, Junius, 2003.
35. Höffe O: Gerechtigkeit. Eine philosophische Einführung. München, Beck, 2004.
36. Aristoteles: Nikomachische Ethik. Stuttgart, Reclam, 1969.
37. Dobrow MJ, Goel V, Upshur RE: Evidence-based health policy: context and utilisation. Soc Sci Med 2004;58:207-217.
38. Gibson JL, Martin DK, Singer PA: Priority setting in hospitals: fairness, inclusiveness, and the problem of institutional power differences. Soc Sci Med 2005;61:2355-2362.
39. Gibson JL, Martin DK, Singer PA: Setting priorities in health care organizations: criteria, processes, and parameters of success. BMC Health Serv Res 2004;4:25.
40. Peacock S, Ruta D, Mitton C, Donaldson C, Bate A, Murtagh M: Using economics to set pragmatic and ethical priorities. BMJ 2006;332:482-485.
41. Mittelverteilung im schweizerischen Gesundheitswesen. Zusammenfassung der Befunde und Empfehlungen; in Schopper D, Baumann-Hölzle R, Tanner M (eds): Schweizerisches Tropeninstitut, Dialog Ethik, 2001.
42. Gibson JL, Martin DK, Singer PA: Priority setting for new technologies in medicine: A transdisciplinary study. BMC Health Serv Res 2002;2:14.
43. Black N: Evidence based policy: proceed with care. BMJ 2001;323:275-279.